• Study of the Reduction of the Prescriptions of Benzodiazepines and Related

  NCT06107283

  Unknown statusObservationalUpdated Oct 30, 2023
• Stopping Benzodiazepines and Related Molecules Among Elderly Living in Residential Institutions

  NCT02715440

  CompletedInterventionalNot ApplicableUpdated Mar 22, 2016
• ZOlpidem and the stRengthening of pRescription regulatiOn

  NCT03584542

  CompletedObservationalUpdated Jan 4, 2022
• How to Ease the Withdrawal of Tranquilizers Among Older Consumers?

  NCT02281175

  CompletedInterventionalNot ApplicableUpdated Mar 31, 2022
• Attitudes and Beliefs Related to Benzodiazepine Deprescribing

  NCT07474532

  Not yet recruitingObservationalUpdated Mar 16, 2026
• Understanding Benzodiazepine and Non-benzodiazepine Sedative Use

  NCT02833272

  Unknown statusInterventionalNot ApplicableUpdated Feb 15, 2017

ClinicalTrials.gov ID

NCT01920581

Lead Sponsor

Nantes University HospitalOTHER

Overall Status

Unknown status

Study Type

Observational

Enrollment

1,100Estimated

Last Update Posted

Aug 12, 2013Estimated

Start Date

Feb 2012

Primary Completion Date

Feb 2014Estimated

Completion Date

Feb 2014Estimated

Official Title

Assessment of Problematic Use of Benzodiazepines and Z Drugs in the Elderly in France: a Public Health Issue

Brief Summary

The aim of this study is to evaluate benzodiazepines and related drugs (zolpidem and zopiclone) usage in an outpatient population of chronic users over 65 years in France using a questionnaire assessing substance dependence according to DSM-IV (Diagnostic and Statistical Manual of mental disorders) international standards.

Detailed Description

1100 patients will be recruited by pharmacists. They will answer to a standardized questionnaire assessing their benzodiazepines or related drugs usage (phone contact).

Pharmacists are recruited by all French Centers For Evaluation and Information on Pharmacodependence (CEIP).

• Chronic Benzodiazepines and Related Drugs Users

Ages Eligible for Study

Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

Yes

Eligibility Criteria

Inclusion Criteria:

• 65 years old or more,
• benzodiazepines or benzodiazepines related drugs treatment for at least three months,
• written consent and without exclusion criteria.

Exclusion Criteria:

• no written consent form
• difficulties to understand or speak french

Observational Model

Case-Only

Time Perspective

Prospective

Lead Sponsor

Nantes University HospitalOTHER

pharmacodependance@chu-caen.fr0231064460

pharmacodependance@chu-grenoble.fr0476765145

pharmacodependance@chru-lille.fr0320961818

jacques-georges.descotes@chu-lyon.fr047216992

ceip@chu-nancy.fr038385291

pascale.jolliet@chu-nantes.fr02 40 08 40 96

samira.djezzar@lrb.aphp.fr0140054266